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A B S T R A C T
Stressors may initially precipitate affective episodes, but with sufficient numbers of recurrences, episodes can
occur more autonomously. It is postulated the memory engram for these recurrent depressions moves from the
conscious representational memory system to the unconscious habit memory system encoded in the striatum. If
this were the case, cognitive behavior therapy targeted toward extinction of habit memories could be an effective
maneuver for helping reverse the automaticity of affective episode recurrence. Extinction training in the
reconsolidation window (which opens about 5 min to 1 h after active memory recall) can revise, reverse, or
eliminate the long term memories associated with PTSD and other anxiety disorders and with drug abuse
craving. We hypothesize that similar cognitive behavioral work in the reconsolidation window could inhibit
stress-induced and spontaneous affective episodes. Some initial formulations of possible therapeutic strategies
are presented and discussed, as well as caveats. It is hoped that preliminary exposition of this theoretical
approach to recurrences in the affective disorders based on principles dependent on work in the reconsolidation
window will lead to more detailed elaboration of the therapeutic maneuvers most likely to be successful and
ones that can be specifically tested for their clinical efficacy.
1. Introduction
1.1. Background on memory formation, consolidation, and re-
consolidation
Memory formation goes through successive stages of encoding.
Hippocampally-based short term memory has long been known to
require consolidation into long term memory in the cerebral cortex by a
process that requires gene expression and new protein synthesis. In
2000, Nader et al. (2000, 2013) discovered a new later phase in
memory storage called reconsolidation. Reconsolidation occurs after a
long term memory is actively recalled and the old memory is
reprocessed in such a way that it again requires new protein synthesis
(Fig. 1). In addition to memory recall, there must be novel information
or context for opening of the reconsolidation window (Agren, 2014;
Ecker, 2015). Fig. 2.
During this phase of reconsolidation, the memory trace becomes
labile and subject to long term revision by psychological processes
occurring within the reconsolidation window which lasts approximately
5 min to 1 h (and possibly up to 5 h) after the active memory recall. The
original memory trace can either be further strengthened with each
new reconsolidation experience or modified and revised if the circum-
stances and requirements for new learning are met. Ecker (2015)
describes “reconsolidation as having two biological functions: (a) It
preferentially strengthens recent learnings that are most frequently
reactivated and destabilized, and (b) it allows new learning experiences
to update (strengthen, weaken, modify, or nullify) an existing learning.”
In this manuscript we review some of the pertinent clinical and
preclinical data on the use of new learning within the reconsolidation
window to alter conditioned fear and memories of positive drug
experiences that drive addiction. How these concepts might then be
utilized in psychotherapy to attempt to prevent the recurrences of
depression are preliminarily outlined, and how these effects could be
potentiated by medications is discussed. The potential for exacerbation
as well as positively modifying emotional learning is also described.
Thus, it is hoped that the current exposition of the role of reconsolida-
tion memory in the psychotherapeutic process will provide further
background information for clinicians and investigators wanting to
utilize these concepts in the development of more systematic ap-
proaches to preventing depressive episodes in the recurrent mood
disorders.
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1.2. Conditioned fear: erasure in the reconsolidation window
The memory trace of a conditioned fear association in humans
(Agren et al., 2012) can essentially be erased if extinction training
occurs in the reconsolidation window, but not at 6 h after recall (by
which time the reconsolidation window has closed). In the study of
Agren et al. (2012), the appearance of a specific photograph (the
conditioned stimulus, cs) that was repeatedly associated with a mild
shock (the unconditioned stimulus, ucs) acquired conditioned stimulus
properties and the picture itself came to evoke a fear response. Sight of
the picture was also associated with activation of the amygdala as seen
on functional magnetic resonance imaging (fMRI) and with changes in
skin conductance even when no shock is given.
However, after active recall of the memory linking the picture with
the shock, the conditioned fear memory trace could be revised by
extinction training within the re-consolidation window, ie the repeated
Fig. 1. There are two phases of memory consolidation. Short term memory requires new protein synthesis for I. CONSOLIDATION into long term memory. Active recall of the long term
memory in the presence of new information (what has been called mismatch prediction error) activates a phase of II. RECONSOLIDATION, which renders the old memory amenable to
revision during a window of about 5 min to several hours after recall. It again requires new protein synthesis. In the RECONSOLIDATION phase the memory can either remain intact
and be strengthened (if there is no mis-match) or revised in the presence of new information.
Fig. 2. This study of Agren et al. (2012) shows that in normal volunteers extinction training within the reconsolidation window (the 10 min group) reduces conditioned fear and
eliminates the associated amygdala activation seen on the fMRI. These positive results do not occur if the same extinction training is conducted outside of the re-consolidation window
(the 6 h delay group).
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exposure to the picture not followed by the shock. The specific picture
eventually ceases to evoke fear subjectively or objectively as measured
by the changes in skin conductance previously seen. Remarkably, the
fMRI study reveals that the amygdala activation which had previously
occurred upon presentation of the picture (the former conditioned
stimulus) also no longer occurs.
If however the exact same extinction training is conducted 6 h after
active recall of the cs-ucs pairing, the conditioned fear response
remains intact along with changes in skin conductance and the
amygdala activation persists. Thus, both active memory recall is
required to open the re-consolidation window and the extinction
training (new information or expectancy mis-match) must take place
in the 5 min to several hour time frame. The active recall renders the
memory trace labile and subject to long term if not permanent revision
and the amygdala-based memory trace is taken off line (Agren et al.,
2012).
Ecker (2015) and Sevenster et al. (2013) emphasize that it is not
just active recall and memory reactivation that is sufficient to open the
reconsolidation window, but a new set of expectancies must be present
as well, which Ecker labels as mismatch prediction error. The
expectancy is that the conditioned stimulus will be followed by a shock
and when this does not occur there is new information that is at odds or
mismatched with the prior learning. Viewed from this perspective,
when there is no mismatch, memory is reconsolidated and the fear
memory persists.
It is noteworthy that the procedures and their temporal sequence
involved in Eye Movement Desensitization and Reprocessing (EMDR)
which has been used for rapid treatment of post traumatic stress
disorder (PTSD) would appear to make implicit use of the same
principles of active trauma memory recall followed by reworking of
the memory in the re-consolidation window (Hogberg et al., 2008).
However, in EMDR eye movement tracking is also employed and some,
but not all literature supports the potential importance of this added
ingredient. Similar therapeutic work in the re-consolidation window
(without associated eye tracking) has been used in the treatment of
anxiety disorders and PTSD (Schwabe et al., 2013, 2014), and even
more remarkably in the treatment of animal and human addictions as
noted below. Ecker (2015) emphasizes: “In a juxtaposition experience,
the client lucidly experiences both the problematic original learning or
schema and a contradictory, disconfirming new learning in the same
field of awareness—not just the desired new experience by itself.”
1.3. Revision of addiction memories and decreased proneness to
relapse
For example, Xue et al. (2012) and Sartor and Aston-Jones (2014)
showed that cocaine re-instatement in the rodent (frantic pressing a
bar that had previously delivered cocaine, but no longer does) could be
prevented by extinction training in the re-consolidation window, but
not outside of it. Xue et al. (2012) took these preclinical findings into
the human arena and validated that these procedures work in patients
who were addicted to heroin and cocaine. Normally when an addicted
individual undergoes traditional therapy and abstinence in a hospital
or jail, they are at very high risk for relapse when they are re-exposed to
the environment where they typically used drugs, see drug parapher-
nalia or other drug cues, or ingest tiny amounts of drug.
However, in humans addicted to heroin (Xue et al., 2012), the
extinction training immediately after active recall of the positive drug
experience (while watching an appealing drug-related video) resulted
in long lasting (up to 180 days) decreases in subjective drug craving, an
absence of relapse, and a lack of the blood pressure increases (mediated
by the autonomic nervous system) that had previously accompanied
exposure to drug cues (Fig. 3). All of the same procedures after
watching a neutral video (which fails to open the re-consolidation
window) resulted in prominent relapses and blood pressure changes
upon cue presentation. Saladin et al. (2013) also showed that post-
retrieval propranolol could transiently alter re-consolidation memory
for craving in cocaine dependent patients.
2. Conceptual formulation of the recurrent affective
disorders
2.1. Successive stages of evolution of recurrent affective illness based
on sensitization to stressors, episodes, and substances of abuse
We now ask how and whether these clinical data and concepts of
extinction training in the re-consolidation window might be applied for
therapeutic intervention in the recurrent affective disorders. Kraepelin
(1921) originally observed that initial episodes of affective disorder
were often triggered by psychosocial stressors, but with enough
recurrences they could begin to occur with more minor stressors, mere
anticipation of stressors, or more automatically with no stressors at all.
We have reviewed the literature which is largely consistent with these
observations and further codified them in the frame work of the
kindling and sensitization model of the recurrent affective disorders
(Post, 1992, 2007, 2008, 2010, 2013, 2016a, 2016b).
The findings of episode sensitization (faster recurrences as a
function of number of prior episodes) has been most clearly validated
in the reviews and work of Kessing et al. (Kessing and Andersen, 2001;
Kessing et al., 1998). Stress sensitization (increased reactivity to
recurrence of stressor) has been validated in multiple types of
laboratory (Antelman, 1988; Kalivas and Stewart, 1991) and clinical
studies. For example Caspi et al. (2003) showed that stressors in
adulthood precipitated depression only in the context of prior child-
hood adversity, particularly with greater number or severity of the
stressors. There has been some ambiguity about the consistency of the
gene-environment interaction that is specifically related to the short
form of the serotonin transporter that Caspi et al. (2003) and others
have observed. However, meta-analyses clearly support the basic
proposition that childhood stressors and traumas sensitize to adult
stressors in precipitating depressions (Risch et al., 2009; Rutter, 2008).
Similarly, Shonkoff and Garner (2012) emphasize how childhood
traumas and their accumulation provide the fertile soil for later
emergence in adulthood of not only major psychiatric problems such
as depression and suicidality, but also multiple physical illnesses as
well. These data help bridge the conceptual gap that childhood traumas
not only are vulnerability factors to the later occurrence of PTSD, but
also of depression and many other difficulties. The type of trigger in
adulthood may be relevant to the different outcomes, with traumas
associated with the threat of loss of life or limb resulting in PTSD, while
those related to psychological and relationship losses more likely to
result in depression. Ecker (2015) describes a case example of a child
repeated traumatized by frightening anger from his parents where the
subsequent vulnerability to depression can be a learned process
occurring outside of the child's awareness. He states: “This learning
can occur with no representation in conscious thoughts or conceptua-
lization, entirely in the implicit learning system”.
The sensitization to stressors has been systematically demonstrated
clinically in recurrent depressed patients by Kendler et al. (2000, 2001)
and Slavic et al. (2011). They showed that the first 5–7 episodes of
recurrent unipolar depression were linked to the occurrence of
psychosocial stressors, but thereafter episodes began to appear more
autonomously or without the need for obvious psychosocial triggers.
This point is of importance, as some have suggested that the persistent
triggering of new episodes by stressors or continued occurrences of
stressors late in the course of illness is evidence against a sensitization
process (Bender and Alloy, 2011; Hammen and Gitlin, 1997).
However, this is what would be expected from the sensitization
perspective; patients would be more, not less, sensitive to stressors
(and their precipitation of depression), but with sufficient numbers of
recurrences such triggers would no longer be necessary and autono-
mous episodes would also begin to emerge as well. Other ambiguities in
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the data and critiques of the sensitization/kindling hypothesis are
comprehensively discussed by Bender and Alloy (2011).
These observations are analogous to the temporal sequence of
behaviors occurring in electrical kindling of seizures following daily
stimulation of the amygdala (Goddard et al., 1969). Initially once daily,
1 s stimulations of the amygdala that are subthreshold for behavioral
response begin to evoke increasingly more complex, first unilateral
forepaw involvement, then bilateral full-blown major motor seizures
with rearing and falling. Following enough of these stimulation-
induced triggered episodes, seizures also begin to occur spontaneously
(Pinel, 1983).
Goddard and Douglas (1975) envisioned the kindling process as
behavioral evidence of a learning and memory process taking place at a
molecular level, such that memory of prior stimulations resulted in
increased physiological and behavioral responsivity over time. While
prolonged affective episodes in humans are not in any way homologous
with brief (usually about 1 min) seizure episodes in kindling, the
progressive evolution to full blown episodes following repeated stimuli
and the subsequent transition from triggered to spontaneous episodes
share a temporal sequence and evolution that may be a useful in
conceptualizing some of the underlying memory-like processes mediat-
ing these phenomena.
Thus, kindling is a non-homologous model for the progression of
the stages of stressors beginning to trigger affective episodes, then
regularly triggering episodes, and finally episodes occurring in the
absence of stressors. Effective treatment in the initial development
phase of amygdala kindling delays the onset of full-blown episodes, and
early intervention against full-blown seizures makes them less prone to
develop tolerance to anticonvulsant drugs and precludes the emergence
of the late, spontaneous episodes. These data in the kindling paradigm
suggest the possibility that early intervention may also be helpful in
heading off later stages of affective illness development.
Sensitization to episode recurrence could also be conceptualized
more directly from the perspective of the reconsolidation process. Each
new trigger and associated affective episode could be viewed as opening
the reconsolidation window in a new set of circumstances and
environmental cues and therefore lead to further generalization and
reconsolidation rather than attenuation of the recurrence process
(Hogberg et al., 2008). In this formulation each new depression would
bring new experiences into the depressive engram via layering and re-
layering of memory in the reconsolidation window, which could
ultimately result in stimulus generalization and the more automatic
emergence of depressions without obvious psychosocial precipitants.
Conversely, as discussed below, following memory recall, therapeutic
maneuvers in the reconsolidation window could theoretically attenuate
this automaticity.
2.2. Cross sensitization among stressors, mood episodes, and
substances of abuse
Animals also show sensitization (increased reactivity) upon repeti-
tion of stressors and bouts of cocaine abuse, and these altered
responses necessarily must be based on a prior learning or neural
encoding of the previous experience (Antelman, 1988; Esparza et al.,
2012; Kalivas and Stewart, 1991). Moreover, sensitization to stressors
can cross sensitize to cocaine sensitization and episode sensitization,
creating a vicious positive feedback cycle where relapses and recur-
rences in one domain can enhance the others and drive illness
progression (Post et al., 2013; Post and Kalivas, 2013). It appears that
with repetition, each type of sensitization becomes more automatic and
based in the striatum (Kalivas, 2008).
We originally postulated (Post, 1992) that with repetition, the
neural substrates encoding stress, episode, and substance abuse
sensitization increasingly moved from those involved in the conscious
representational memory system of the medial temporal lobe (amyg-
dala and hippocampus) which is subject to conscious recall to the habit
memory system of the striatum which can occur on a non-conscious
basis (Mishkin and Appenzeller, 1987). This type of habit memory is
typified by the procedural learning involved in learning to ride a
bicycle, which becomes increasingly automatic and is never forgotten
(Kalivas and Kalivas, 2016). This transition into the habit memory
system of the striatum is clearly the case for cocaine sensitization which
involves increases in BDNF in the ventral striatum (nucleus accum-
bens), and then comes to involve the dorsal striatum.
Fig. 3. Patients addicted to cocaine or heroin do not experience drug craving, blood pressure changes, or spontaneous or cued relapsse for up to 6 months when extinction training is
conducted within, but not outside of, the reconsolidation window after active memory recall (viewing a video of drug cues), but not after a 6 hour delay.
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Interestingly, in mice, defeat stress-induced depressive-like beha-
viors, such as social avoidance and not seeking sweet or rewarding
substances, are also associated with increases in brain derived neuro-
tropic factor (BDNF) in the ventral striatum, and clinical depression in
humans is also associated with increases in BDNF in the same area.
Since BDNF is critical to the generation and persistence of long term
memory, one way of viewing these convergent biochemical findings
would be to consider stress sensitization, cocaine sensitization, and
depressive episode sensitization as manifestations of over-learned
pathological habits occupying the dopamine-based reward systems of
the ventral striatum, and with increasing repetition, involving the
dorsal striatum (Kalivas and Kalivas, 2016; Post and Kalivas, 2013). As
discussed below, each type of sensitization appears to have an
epigenetic basis, as blockade of DNA methylation or other epigenetic
mechanisms, inhibits the behavioral sensitization to recurrent stres-
sors, cocaine use, or defeat stress-induced depression (Post, 2016a).
In Ecker's (2015) example of the boy who repeated experiences
frightening anger from his parents and then develops depression,
anxiety, withdrawal, and other negative behaviors, he states “the neural
circuits encoding these learnings are mainly in subcortical regions of
implicit memory that store implicit, tacit, emotionally urgent, proce-
dural knowledge, not mainly in neocortical regions of explicit memory
that store conscious, episodic, autobiographical, declarative knowl-
edge.”
2.3. N-acetylcysteine as a possible example of a single therapeutic
approach having therapeutic effects in multiple habits
The cross sensitization among stressors, affective episodes, and
cocaine implies some mechanisms in common are involved, such as the
BDNF increases in the striatum. However, common mechanisms also
suggest the possibility of common pharmacological or psychological
approaches to all three types of sensitization. One possible drug
example, is N-acetylcysteine (NAC) which is readily-available (from
health food stores). There are preliminary data that NAC has positive
effects in depression and anxiety in bipolar disorder (Berk et al., 2008)
and may decrease a variety of addictions (including cocaine, gambling,
marijuana, alcohol, and nicotine), and habits such as trichotillomania,
obsessive compulsive disorder, and stereotypy in autism (reviewed in
Kalivas and Kalivas (2016) and Post (2016a)). However, not all studies
are positive and further systematic study of each syndrome is required.
While NAC has multiple mechanism of action as an anti-oxidant, a
glutathione precursor, and an anti-inflammatory substance, it has one
action that could account for its positive effects across a range of
sensitized behaviors and habits. NAC decreases hyperactive glutamate
signaling in the accumbens induced by multiple habits by increasing
the number of glutamate transporters on glial cells, which pull
glutamate out of the synapse. This lowers the intensity of the striatal
habit system, allowing greater volitional cerebral cortical control
(Kalivas and Kalivas, 2016; Post and Kalivas, 2013).
Kalivas at MUSC found that cocaine addiction in animals markedly
increased glutamate signaling in the ventral striatum, ie the nucleus
accumbens (or reward area of the brain) and hypothesized that NAC
would decrease the glutamate signal and prevent cocaine re-instate-
ment in addicted animals (Kalivas and Volkow, 2011). In some but not
all subsequent studies, NAC decreased craving and relapse clinically in
addicted individuals (Kalivas and Kalivas, 2016; LaRowe et al., 2013).
Cocaine addicted animals lose the ability of the cortex to modulate
the activity of the nucleus accumbens as cocaine impairs the molecular
mechanisms of learning, memory, and plasticity of long term potentia-
tion (LTP) and long term depression (LTD) in the pathway from cortex
to accumbens (Moussawi et al., 2009, 2011). In cocaine addicted
animals, treatment with NAC restores LTP and LTD, allowing new
learning and flexible responses to environmental contingencies. Similar
dampening of the glutamate signaling in the striatum could underlie
the ability of NAC to help over come other urges and habits in
trichotillomania, compulsions, PTSD, and a variety of addictions in
humans (Kalivas and Kalivas, 2016). The findings that extinction
training in the reconsolidation window also can inhibit drug seeking
in humans (Agren et al., 2012) and intrusive thinking in PTSD and
related disorders (Ecker, 2015; Nader et al., 2013), further suggests
some commonalities in the ability to alter habits by either pharmaco-
logical or neuropsychological approaches.
3. Therapeutic work in the re-consolidation window for
prevention of recurrent depression
Based on the observations that extinction learning in the re-
consolidation window can decrease PTSD and related trauma mem-
ories as well as the craving and relapse proneness of heroin and cocaine
addicts as noted above, we postulate that related work in the
reconsolidation window would be effective in dealing with the sensi-
tization to and automaticity of recurrent depressions. While stressors
are often the initial triggers for affective episodes early in the course of
illness, the more automatic emergence of episodes following multiple
repetitions may nonetheless be amenable to attenuation by work in the
reconsolidation window in a fashion similar to the automaticity of drug
craving and its associated autonomic increases in blood pressure (Xue
et al., 2012). In PTSD and dysfunctional fear-memory reactions,
Hogberg (2011) states: “The goal of the treatment is to change a
reliving intruding memory into a more distant episodic memory.” In
parallel the aim of treatment in the recurrent affective disorders would
be a reworking of the triggering experience and a rendering of the
depressive experience as less harsh, severe, self-defeating (guilt-indu-
cing).
The neural substrates mediating sensitization to stress and cocaine
evolve over time and the effectiveness of pharmacological intervention
differs as a function of initial development versus later expression of
sensitized behavior (Post et al., 1988). Likewise, since the different
stages of kindling evolution and progression involve a spatio-temporal
spread of neural activity and gene expression that is initially confined
to the amygdala to new brain areas such as hippocampus and then
cortex (Clark et al., 1991; Rosen et al., 1992, 1993), it is again not
surprising that effective pharmacological interventions differ as a
function of the stage of kindling evolution. This is illustrated in
Fig. 4 where some drugs are effective in A. the initial developmental
stage of kindling, but not B. the midphase of fully developed, major
motor triggered seizures. Other drugs do not block A. kindling
development, but are potent against B. the full-blown kindled seizures.
Remarkably there is a double dissociation in the anticonvulsant effects
of phenytoin and diazepam where phenytoin becomes effective in the
prevention of C. the late spontaneous seizures, while diazepam shows
the opposite effect (Pinel, 1983).
In a somewhat parallel fashion, we are hypothesizing that pharma-
cological and psychotherapeutic approaches might differ in different
stages of evolution of the recurrent disorders from: A. the early
developmental stage of stressors triggering minor depressive episodes:
to B. the mid phase of full-blown triggered depressive episodes; and C.
the late stage of spontaneous episodes (Figs. 4 and 5). While there are
only preliminary clinical data supporting this proposition, perhaps the
most clear-cut example is lithium and many other pharmacological
agents becoming less effective after multiple recurrences (Post et al.,
2012). In a similar vein, one could hypothesize that psychodynamic
and insight-oriented therapies would be most helpful in dealing with
initial and stress-related affective episodes, but with stressor and
affective episode recurrence, interpersonal and cognitive behavioral
techniques may be required for reducing perceived stress and increas-
ing cortically based adaptive coping mechanisms. However, with the
transition to late spontaneous episodes and their automaticity of
recurrence, even more habit and implicit memory oriented techniques
might be necessary. The data of Scott et al. (2006) are partially
supportive of this view. They found cognitive behavioral therapy
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(CBT) helped in bipolar patients early in their course of illness, but in
those with a great many prior episodes (presumably in the late phases
of spontaneous episodes), CBT not only was not effective, but appeared
to be counter productive.
Thus, in this later phase of illness evolution involving spontaneous
episodes, different techniques may again be required, one of which
could involve altering habit memory by work in the reconsolidation
window. In partial contrast to this view of different therapeutic
approaches as a function of the course of illness, Lane et al. (2015)
see work in the reconsolidation window being amenable to all types
and stages of memory mechanisms as noted below. How work in the
reconsolidation window could be best applied to those with recurrent
affective episodes would have to be assessed with initial exploratory
work in individual patients and in proof of principal studies before
more large-scale clinical trials were attempted. An example or two of
how these techniques could be conceptualized and applied are pre-
liminarily outlined.
The longitudinal history of an individual's course of illness would be
taken in detail to assess early (distal) stressors and traumatic events in
childhood, and the history of more adult difficulties and (proximal)
stressors that may be involved in the acute precipitation of depression.
Finally, in those with highly recurrent episodes, acute stressors if any,
Fig. 4. The different stages of amygdala kindled seizure development are schematized: A. Stimulations evoke seizure of increasing complexity; B. Stimulations regularly trigger full-
blown seizures; and C. Seizure emerge in the absence of amygdala stimulation. The first 2 drugs block A. the Development but not B. Completed (fully kindled) seizures, while
carbamazepine and lamotrigine show the opposite patten of efficacy. In contrast, valproate and levetiracetam are effective in inhibiting seizures in both the Development and Completed
phases. Phenytoin and diazepam are noteworthy for their double dissociation. Diazepam is effective in A. Early and B. Mid phases of kindling, but not on the late spontaneous seizures,
while phenytoin essentially shows the opposite pattern. These data raise the question of whether different pharmacological agents may differ in their efficacy as a function of stage of
illness evolution in the affective disorders, as schematized in Fig. 5.
Fig. 5. As in the stages of kindled seizure evolution; A. full-blown affective episodes (in blue) emerge with repeated stressors (in yellow, S 1–3), then B. Full-blown episodes are regularly
triggered by stressors (S 3, 4), and finally in C. Spontaneous episodes can occur in the absence of triggers. The neurobiological and anatomical substrates (in red) and memory
mechanisms (in blue) may also differ and evolve as a function of these stages of illness progression. (For interpretation of the references to color in this figure legend, the reader is
referred to the web version of this article.)
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would need to be further explored, as would the most current episodes
potentially occurring more spontaneously without obvious triggers.
Once this longitudinal evaluation has been completed, one would have
to decide which types of stressors were, or previously had been, the
most important triggers. One might then try to work in the re-
consolidation window opened by the evocation of the most prominent
and emotionally laden memories, be they from childhood, early
adulthood, or the most recent epoch.
Alternatively, as a starting point it may be most advantageous to
initially work with patients who have identified stressors as critical
triggers of their depressive episodes, and only after seeing success in
this domain begin to work with patients who have entered the phase of
automaticity of episodes. However, even in this latter instance, it might
be most expeditious to work with patients who had previously
recognized the role of stressors as precipitants prior to episodes
becoming more automatic.
One might then proceed by having the patient evoke the memory
and its associated emotion as part of the recall procedure in order to
renew the lability (amenability to change) of this memory trace in the
re-consolidation window. The evocative recall could then be immedi-
ately followed by a re-working of the traumatic memory from multiple
perspectives and in the safe environment of the therapeutic relation-
ship. These might include: reframing the traumatic memory, empha-
sizing the adaptive components of the response, the youth of the child
(if this were the case), addressing any guilt associated with participa-
tion in the behavior, and many of the other techniques described in
literature on traumatic memories and psychotherapy. Hogberg et al.
(2011) suggests that activating positive affect in the work in the
reconsolidation window involves increasing parasympathetic tone,
which “can be achieved by relaxation exercises: breathing and medita-
tion, safe-place imagery, perhaps walking on a treadmill or bicycling on
a spinning cycle.”
In addition to traumatic memory, similar work in the reconsolida-
tion window could proceed in relationship to the depressive experience
itself and the patients overwhelming negative view of the self and the
future. Lane et al. (2015) make the case that work in the reconsolida-
tion window could target all of the components of what they call the
integrated memory structure, which would include: emotional re-
sponses (using behavior therapy): episodic memory (using psychody-
namic psychotherapy); and semantic structures (using cognitive-beha-
vioral therapy). In each of these approaches, the therapist is attempting
to help the patient in “updating of prior emotional memories through a
process of reconsolidation that incorporates new emotional experi-
ences… into these reactivated memories via the process of reconsolida-
tion”. The Lane et al. (2015) article merits careful reading for the
wealth of information and insights into how work in the reconsolida-
tion window mediates change in psychotherapy and can be utilized in
multiple therapeutic domains. Ecker (2015) concludes that “profound
unlearning and cessation of acquired behaviors and states of mind
occurs through the process of memory reconsolidation,”.
3.1. What is different in this exposition
One might criticize this approach to recurrent depression utilizing
the reconsolidation window as not novel and that it is merely using
techniques already used in many existent therapies. While this view has
some merit, what is novel here is the specifics of the procedure
involving active memory recall to open the reconsolidation window in
the presence of a mismatch of expected outcomes, and then attempting
in therapy to more permanently modify the emotional and associative
impact of the memory and its potential for triggering new episodes.
Some of the variables that could result in further exacerbation or
reconsolidation of the original emotional memory are also made more
explicit as discussed below. Moreover, the potential of enhancing the
positive effects with adjunctive physiological or pharmacological ap-
proaches, including those making use of information about the role of
epigenetic mechanisms in normal memory processes is also new.
The link of memory to re-triggering of affective episodes also opens
new possibilities of therapeutic work in multiple temporal domains of
illness evolution. These might include those related to childhood and
adolescent adversities as well as those related to triggering of depres-
sions in, early and late adulthood. This exposition also puts a new set of
principles based on more precise preclinical and clinical experience
into the equation that then can be tested in individuals and modified as
new experience is gained. The paradigm would also be further
informed by the ongoing clinical, laboratory, and conceptual work on
this phase of memory re-consolidation, and as new insights and
information are gleaned from the basic and clinical neuropsychiatric
literature, the procedures most pertinent to the affective disorders
could be further modified and adapted accordingly.
3.2. Conundrums for future study
As noted above, one of the many questions that emerges from this
formulation regarding stressor desensitization and extinction is
whether the work in the re-consolidation window should focus on the
original traumas (in childhood) or on the more proximal stressors,
which initially triggered mood episodes in adulthood. Manic episodes
could also be the target of such work with their positive reward-
engendering characteristics similar to cocaine-induced craving and
euphoria and dysphoria. Depressive feeling and cognitions could also
be a target for the extinction procedures even after they have started to
appear autonomously. Thus how to sequence the extinction procedures
for optimal therapeutic results and apply them to the appropriate phase
of illness evolution would be a major theme for study in the clinical
development of this strategy.
Another unanswered question is for which patients this technique
would be most appropriate and which other types of patients would be
most unlikely to benefit. We would surmise that those patients who
readily recognized the role of stressors in triggering their episodes early
in their course of illness would be among the best candidates with
whom to begin work. However, strategies designed to elicit emotions
and amygdala activation associated with an individual's unique sense of
threat to status, autonomy, or relationships may provide a template for
work in the reconsolidation window in an individual who has not yet
fully identified his areas of vulnerability.
Ecker (2015), Agren (2014), and Lane et al. (2015) all make the
point that work in the reconsolidation window is appropriate for a
whole range of types of learning and memory from declarative to
appetitive memories, procedural memories, and fear memories. To this
extent, work in the reconsolidation window may be pertinent to many
stages of affective illness evolution. The research directions suggested
in this manuscript are thus very much in line with others’ work and
ideas about therapy. Ecker (2015) explicitly states that it is a
misconception to believe that work in the reconsolidation window is
pertinent only to fear-based learning, and clinicians already have
enough information to begin to apply this concept to “a wide range
of clinical conditions (that) also are rooted in and driven by implicit
memory.”
One would also have to pay careful attention to the possibility that
the memory recall could further kindle pathological emotional re-
sponses rather than help extinguish them. This caution is discussed
further by Nader et al. (2013) and Schwabe et al. (2013), and others in
the PTSD literature have approached this problem with techniques to
minimize this possibility. These include: graded recall, blunting the
emotional recall with propranolol, etc., but whether such attempts
would impair the ability of the recall to actively open the re-consolida-
tion window would have to be assessed. Other attempts have also be
made to reduce the stress with the beta noradrenergic antagonist
propranolol (Otis et al., 2015; Pitman et al., 2012) and mineralocorti-
coid receptor blockade with spironolactone which prevents stress from
promoting striatum-based learning at the expense of hippocampus-
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based declarative learning (Schwabe et al., 2013). One study with
propranolol showed that different memory traces of learned fear do not
necessary undergo reconsolidation simultaneously as propranolol re-
duced fear-potentiated startle, but not skin conductance responses, or
the subjective anticipation of fear (Soeter and Kindt, 2012).
Additionally, how this work on extinction in the re-consolidation
window could be enhanced by the principles of cognitive training and
rehabilitation would be another area for productive exploration.
Vinogradov et al. (2012) emphasize how increases in lower level
cognitive training can yield positive results on higher level cognitive
operations and how work on implicit learning can result in positive
effects on explicit learning. Vinogradov et al. (2012) also emphasize the
importance of repetition and number of trials, as well as immediacy of
reward to maintain motivation in cognitive training. In this fashion it
might be considered how (passive) extinction training in the re-
consolidation window could be augmented with (active) new learning
of adaptive responses to stressful triggers in order to minimize threats
to the self in attempts to optimize the possibility of preventing affective
episode recurrence. Listing, recalling, and rehearsing potential adap-
tive alternative responses to perceived threats followed by immediate
reward and encouragement of the therapist may add new elements of
learning positive ways of responding to the task of extinction training
rather than just the re-working of old stimulus-response habit mem-
ories.
3.3. Possible augmentation strategies
How psychological work in the re-consolidation window could be
integrated with other therapeutic modalities that have already been
studied in humans might be an additional fruitful topic of future
research. For example, D-cycloserine is a partial agonist at glutamate
NMDA receptors and its augmentation of glutamatergic tone has been
shown in some studies to enhance the new learning required for
extinction of clinical phobias and other anxiety disorders (Gupta et al.,
2013; Norberg et al., 2008; Ressler et al., 2004), although a recent
study of its effects as augmentation of CBT in OCD was not positive
(Storch et al., 2016). Additionally, the D-cycloserine effects are short
lived and subject to tolerance development. One could look for other
modalities that could generate a D-cycloserine-like enhancement of
new learning, such as methylene blue, which enhances fear extinction
in claustrophobia (Telch et al., 2014), increases mitochondrial cyto-
chrome oxidase in neurons that are the most active, and improves
residual symptoms in bipolar depression (Alda et al., 2016).
Another candidate would be repeated transcranial magnetic stimu-
lation (rTMS), which regionally stimulates neurons and increases the
release of glutamate and BDNF, as well as dopamine in the striatum.
We have postulated that high frequency (10–20 Hz) rTMS which
induces LTP in the hippocampus and increases regional brain activity
measured in patients with O15 positron emission tomography (PET)
scans in a long lasting fashion might be optimal for enhancing new
learning needed for extinction in structures such as the medial
prefrontal cortex (Post and Speer, 2007; Speer et al., 2000, 2009).
Therapeutic work during the rTMS would be postulated to enhance
experience dependent neuroplasticity. Conversely, low frequency (1–
5 Hz) rTMS induces LTD, and it decreases regional brain activity that
might be helpful in taking emotional memory off line. How such
opposing physiological processes could be best integrated into the
neuropsychological work with extinction training would require further
specific exploration and testing.
Another option worthy of future exploration is the co-administra-
tion of a drug such as valproate (Depakote) with the extinction work
within the reconsolidation window. This clinically available and widely
used drug has so far only been used in preclinical models of learning
and memory. Valproate is a potent histone de-acetylase inhibitor which
has been shown to increase the specific BDNF variant - BDNF exon IV
mRNA expression - needed for extinction learning (Bredy et al., 2007).
Valproate has also been shown to enhance extinction learning in
animal models.
The potential use of valproate as a histone de-acetylase inhibitor to
enhance extinction also raises the whole issue of how a range of
epigenetic mechanisms (such as DNA methylation, histone modifica-
tions, and micro RNA) which have be intimately implicated in learning,
memory, and the mood disorders (Nestler, 2013, 2014; Zovkic and
Sweatt, 2013) could be further exploited for enhancement of new
learning and extinction procedures. Post (2016a) has reviewed the
evidence that epigenetic alterations are critically involved in sensitiza-
tion to recurrent stressors, mood episodes, and bouts of substance
abuse. The elucidation of how the processes of reconsolidation interact
with or are mediated by specific epigenetic mechanisms will be a very
exciting area of future investigation.
The studies of Bredy and Barad (2008) on valproate also raise a
series of important issues about the competing processes for either
memory enhancement (re-consolidation) or extinction of conditioned
fear, and that according to the “strength dominance hypothesis” the
strength and duration of the stimulus at the time of reactivation as well
as the inter-trial interval of the extinction training determines which
type of memory (re-consolidation or extinction) is reactivated. When
they gave valproate with seven massed trials (5 s apart), the original
context dependent fear memory was further enhanced. When valproate
was given with seven spaced trials (20 min apart), extinction memory
was not only enhanced but became context-independent. This study
thus further clarifies the critical nature of the characteristics and timing
of the extinction protocol for achieving the desired lessening of the fear
or drug memory versus further re-consolidating it. Valproate, based on
its histone de-acetylase inhibition effects, can thus enhance either one
of the competing memory traces of re-consolidation or extinction.
Bredy and Barad (2008) conclude: “Perhaps administering VPA in
combination with brief, spaced cue exposures may yield a more
effective and more generalized therapeutic result.”
Ketamine administered intravenously has recently been shown to
be acutely (within 2 h) effective in relieving refractory depression and
its accompanying suicidality (Murrough et al., 2013). It has also had
some success in the treatment of PTSD (Feder et al., 2014). Ketamine's
behavioral antidepressant-like effects in chronically stressed rodents
are accompanied (also within 2 h) by a return from immature, spike-
shaped dendritic spines to mature mushroom-shaped dendritic spines
(Li et al., 2011), Thus, ketamine's ability to restore normal synaptic
structure may be a way of enhancing new learning in the reconsolida-
tion window, or conversely work in the reconsolidation window may be
a way of extending the duration of the antidepressant effects of iv
ketamine which usually last only 3–5 days.
3.4. Further caveats
As noted above, one would have to pay careful attention to the
temporal characteristics of the recall of the traumatic or euphoric affect
(and the hoped-for extinction learning trials) so that the recall does not
provide a counter-productive new kindling-like experience or a further
sensitizing stimulus rather than new extinction learning. Schwabe et al.
(2014) describe uncertainty about the boundary conditions that affect
re-consolidation, such as: the age and strength of the memories, the
reminder structure, the context and frequency of the reactivation, the
presence of new information at the time of reactivation, the experience
of stress after memory reactivation, and even the length of the
reconsolidation window. As many of these questions are bettered
answered in the future with new clinical and preclinical data, they will
further guide the development of the optimal paradigms for extinguish-
ing fear, drug craving, and as discussed here, the possibility of stress-
induced precipitation of affective episodes or their automaticity.
One might raise the concern that attempts at memory revision and
erasure or memory erasure drugs are problematic from an ethical
perspective. However, we and others do not believe that the drugs
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described are memory erasure drugs, but drugs that facilitate new
learning. Ecker (2015) states: “When a learned, unwanted emotional
reaction is erased, there is no loss of memory of events in one's life”.
Therefore we would hope that this work would fall under the rubric of
many other types of psychotherapy that attempt to reduce unwanted
and unproductive emotional and behavioral reactions, rather than
memory erasure per se.
It is also unclear how to best focus efforts at extinction learning on
stressors as a function of temporal evolution of affective episodes from
those earliest in childhood (which may not be accompanied by an
episode); to stressors in adulthood that are regularly associated with
episode occurrence, or on the late, presumably, conditioned stress
responses that yield episodes that appear un-triggered. For example, it
is possible that work on extinction of the stress-related triggering of
initial affective episodes may be more productive than later work once
the phase of spontaneity has been reached. Moreover, it is possible that
extinction work early in the phase of triggered episodes could pre-empt
the later more rapidly-recurring, triggered episodes as well as their
conversion to the spontaneous variety in parallel to the effects seen
preventing amygdala kindled seizures. In this fashion, early interven-
tion for triggered episodes could be viewed as an attempt at secondary
and tertiary prevention of subsequent illness recurrence and progres-
sion.
4. Conclusions
Given this multiplicity of unanswered questions, the current
formulation about using therapeutic maneuvers in the reconsolidation
window to attempt to prevent depressive recurrences is far from
complete. It is hoped, nonetheless, that it will provide an initial
framework for further exploration and development of psychothera-
peutic approaches specifically aimed at revisions of automatic habit-
based learning associated with affective episode occurrence and
progression to spontaneity.
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